IMMUCELL CORP /DE/ reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Portland, ME
SEC filing record 1 source field available
Fiscal year end
31 December
IMMUCELL CORP /DE/ has filed 788 SEC EDGAR filings since 03 Aug 1995

SEC filing history

Showing 476-500 of 527 matching filings.

Per page
25
Current page
20
4

4 filing

Filing date
14 Oct 2011
Reporting date
12 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Oct 2011
Reporting date
12 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
08 Sep 2011
Reporting date
02 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
07 Sep 2011
Reporting date
02 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Aug 2011
Reporting date
19 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
15 Aug 2011
Reporting date
15 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jul 2011
Reporting date
08 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Jun 2011
Reporting date
21 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

8-K filing

Filing date
16 Jun 2011
Reporting date
15 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
10 Jun 2011
Reporting date
09 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
16 May 2011
Reporting date
16 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12934

FORM 10-Q

Filing date
16 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12934

DEFA14A

Filing date
18 Apr 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-12934

DEFINITIVE PROXY STATEMENT

Filing date
18 Apr 2011
Reporting date
15 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
15 Apr 2011
Reporting date
08 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

AMENDMENT OF STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
15 Apr 2011
Reporting date
15 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP

Filing date
15 Apr 2011
Reporting date
04 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12934

FORM 10-K

Filing date
28 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
21 Mar 2011
Reporting date
17 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
15 Mar 2011
Reporting date
11 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-39373

SCHEDULE 13D AMENDMENT NO. 1

Filing date
10 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-39373

SCHEDULE 13D AMENDMENT NO. 2

Filing date
10 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
18 Feb 2011
Reporting date
16 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .